.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
McKinsey
Colorcon
Julphar
Accenture
Farmers Insurance
AstraZeneca
US Department of Justice
Baxter

Generated: September 21, 2017

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Lidocaine Hydrochloride, and when can generic versions of Lidocaine Hydrochloride launch?

Lidocaine Hydrochloride is a drug marketed by Intl Medication, West-ward Pharms Int, Belmora Llc, Abraxis Pharm, Bel Mar, Vintage, Hospira, Miles, Hi Tech Pharma, G And W Labs Inc, Elkins Sinn, Watson Labs, Akorn, Gd Searle Llc, Watson Labs Inc, Mylan Labs Ltd, Luitpold, Abbott, Luitpold Pharms Inc, Wockhardt, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Teligent Pharma Inc, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Fresenius Kabi Usa, Aurobindo Pharma Ltd, and Actavis Mid Atlantic. and is included in ninety-three NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for Tradename: LIDOCAINE HYDROCHLORIDE

Patents:0
Applicants:32
NDAs:93
Suppliers / Packagers: see list29
Bulk Api Vendors: see list32
Clinical Trials: see list3,130
Patent Applications: see list6
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIDOCAINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: LIDOCAINE HYDROCHLORIDE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018461-002Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION078772-001May 12, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION083158-001Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION085037-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
lidocaine hydrochloride
INJECTABLE;SPINAL083914-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION080404-003Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
Abbott
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION089362-001May 25, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Intl Medication
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION017702-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION083083-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION091058-002Sep 30, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Cipla
Merck
Daiichi Sankyo
Fish and Richardson
Argus Health
Teva
Citi
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot